{"id":"W4402644711","doi":"10.1038/s41597-024-03869-x","title":"High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma","year":2024,"lang":"en","type":"article","venue":"Scientific Data","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Therapeutic Innovation Australia; BC Cancer Foundation; Medical Research Future Fund; Australian Cancer Research Foundation; Australian Government; Ovarian Cancer Canada; Marshfield Clinic Research Foundation; Cancer Research Society; Peter MacCallum Cancer Centre; Victorian Cancer Agency","keywords":"Serous fluid; Ovarian cancer; Serous carcinoma; Ovarian carcinoma; Oncology; Clear cell; Ovary; Clear cell carcinoma; Internal medicine; Medicine; Cancer research; Drug; Cancer; Carcinoma; Pharmacology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005227824,0.0005480437,0.0009366116,0.0007882802,0.000288094,0.001028568,0.0003755752,0.0005066944,0.001834245],"category_scores_gemma":[0.0006618274,0.0002435468,0.000661566,0.0006601872,0.0002912079,0.0003865105,0.0003547357,0.000653133,0.0005495632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006457228,"about_ca_system_score_gemma":0.0006483176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001845416,"about_ca_topic_score_gemma":0.004583257,"domain_scores_codex":[0.9997125,0.00004625946,0.00002001317,0.00004775967,0.0001358716,0.00003755506],"domain_scores_gemma":[0.9996911,0.0001233962,0.00005509215,0.00003725035,0.00006750887,0.00002568359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001012308,0.000518567,0.01163315,0.0009886444,0.000230958,0.0004102488,0.00008014678,0.01912325,0.9042034,0.0006301706,0.002912395,0.05825662],"study_design_scores_gemma":[0.0001675603,0.002279387,0.02252836,0.00006730989,0.0003017005,0.001086407,0.0001187408,0.04711256,0.9146763,0.0007194485,0.01085769,0.00008445378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9635715,0.006092047,0.01838054,0.0007895236,0.00004573357,0.000292244,0.006756709,0.001015788,0.003055861],"genre_scores_gemma":[0.975934,0.003296102,0.01299228,0.0002573765,0.00001400322,0.0001223495,0.005690466,0.00005513063,0.001638434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001845416,"threshold_uncertainty_score":0.006136179,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1106643983927152,"score_gpt":0.3456806975507206,"score_spread":0.2350162991580053,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}